InvestorsHub Logo
Followers 67
Posts 1293
Boards Moderated 0
Alias Born 08/12/2014

Re: None

Wednesday, 05/25/2022 1:07:47 PM

Wednesday, May 25, 2022 1:07:47 PM

Post# of 700308
On today's smithonstocks article: generally an insightful and plausible rebuttal to AF's said scandalous, distorted, misled article.

Although smith wrongly cited clinicaltrial.gov as source for OS primary and secondary endpoint at the time, Smith's point is still intact because AF had for several occasions openly acknowledged and attacked that Northwest Bio has updated the trial endpoints in both eu and us via tweets well before 10 May 2022 when his said article was published.

As Smith suggests it may be much useful to write to AF's superiors to demand retraction of the misleading article, fire AF, and apologize, which I agree and have done so, than just hang on in this board "complaining or pumping."

We are 35,000 investors strong, if we are united even by 10%, we can do a lot of wonderful things!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News